SCHEMBL7956714

SCHEMBL7956714

c1ccc(COc2ccc(OC3CCN(c4ccncc4)C3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACACB O00763 9/20 0.60
F10 P00742 4/20 0.50
MCHR1 Q99705 1/20 0.50
FFAR4 Q5NUL3 4/20 0.48
HRH1 P35367 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
F2 P00734 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961303 0.93 F10 (0.54) ACACBF10MCHR1FFAR4HRH1
SCHEMBL7956699 0.88 ACACB (0.48) ACACBF10MCHR1FFAR4
SCHEMBL7955313 0.84 ACACB (0.49) ACACBFFAR4
SCHEMBL7961508 0.80 ACACB (0.51) ACACBFFAR4
SCHEMBL7956152 0.79 ACACB (0.52) ACACBFFAR4
SCHEMBL7956662 0.78 ACACB (0.55) ACACBHRH1HRH3
SCHEMBL7956861 0.78 ACACB (0.51) ACACBFFAR4
SCHEMBL7961307 0.78 F10 (0.52) F10HRH1HRH3F2
SCHEMBL7956683 0.78 HRH3 (0.58) ACACBHRH1HRH3
SCHEMBL7958655 0.76 LIPG (0.50) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6313127-B1 FOR THERAPY OF HYPERCHOLESTEROLEMIA OR ATHEROSCLEROSIS ZENECA LIMITED (GB) 2001-11-06 US disclosed
EP-0880501-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1998-12-02 EP disclosed
WO-1997028128-A1 HETEROCYCLIC COMPOUNDS USEFUL AS PHARMACEUTICAL AGENTS ZENECA LIMITED (GB) 1997-08-07 WO disclosed